These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 16984088
1. Effects of semax against the background of dopaminergic receptor blockade with haloperidol. Sebentsova EA, Levitskaya NG, Andreeva LA, Alfeeva LY, Kamenskii AA, Myasoedov NF. Bull Exp Biol Med; 2006 Feb; 141(2):170-4. PubMed ID: 16984088 [Abstract] [Full Text] [Related]
2. [Neuroprotective effects of semax in MPTP-induced disturbances of brain dopamine system]. Levitskaia NG, Sebentsova EA, Andreeva LA, Alfeeva LIu, Kamenskiĭ AA, Miasoedov NF. Ross Fiziol Zh Im I M Sechenova; 2002 Nov; 88(11):1369-77. PubMed ID: 12587264 [Abstract] [Full Text] [Related]
3. The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system. Levitskaya NG, Sebentsova EA, Andreeva LA, Alfeeva LY, Kamenskii AA, Myasoedov NF. Neurosci Behav Physiol; 2004 May; 34(4):399-405. PubMed ID: 15341218 [Abstract] [Full Text] [Related]
6. [Nootropic and analgesic effects of Semax following different routes of administration]. Manchenko DM, Glazova NIu, Levitskaia NG, Andreeva LA, Kamenskiĭ AA, Miasoedov NF. Ross Fiziol Zh Im I M Sechenova; 2010 Oct; 96(10):1014-23. PubMed ID: 21268834 [Abstract] [Full Text] [Related]
8. [An experimental substantiation for using the "Semax" neuroprotector in the treatment of optic-nerve diseases]. Sheremet NL, Polunin GS, Ovchinnikov AN, Kamenskiĭ AA, Levitskaia NG, Andreeva LA, Alfeeva LIu, Nagaev IIu. Vestn Oftalmol; 2004 Oct; 120(6):25-7. PubMed ID: 15678666 [Abstract] [Full Text] [Related]
9. [Kinetics of Semax penetration into the brain and blood of rats after its intranasal administration]. Shevchenko KV, Nagaev IIu, Alfeeva LIu, Andreeva LA, Kamenskiĭ AA, Levitskaia NG, Shevchenko VP, Grivennikov IA, Miasoedov NF. Bioorg Khim; 2006 Oct; 32(1):64-70. PubMed ID: 16523722 [Abstract] [Full Text] [Related]
10. Semax attenuates the influence of neonatal maternal deprivation on the behavior of adolescent white rats. Volodina MA, Sebentsova EA, Glazova NY, Levitskaya NG, Andreeva LA, Manchenko DM, Kamensky AA, Myasoedov NF. Bull Exp Biol Med; 2012 Mar; 152(5):560-3. PubMed ID: 22803132 [Abstract] [Full Text] [Related]
11. [The comparison of neuroprotective action of antibodies to glutamate and drug preparation semax in the focal ischemic damage of the brain prefrontal cortex of rats]. Romanova GA, Shakova FM, Davydova TV. Patol Fiziol Eksp Ter; 2012 Mar; (3):62-7. PubMed ID: 23072114 [Abstract] [Full Text] [Related]
12. [Dependence of neuropeptide physiological effects on a route of administration]. Kamenskiĭ AA, Voskresenskaia OG, Dubynin VA, Levitskaia NG. Ross Fiziol Zh Im I M Sechenova; 2001 Nov; 87(11):1493-501. PubMed ID: 11816281 [Abstract] [Full Text] [Related]
16. [Effects of chronic Semax administration on exploratory activity and emotional reaction in white rats]. Vilenskiĭ DA, Levitskaia NG, Andreeva LA, Alfeeva LIu, Kamenskiĭ AA, Miasoedov NF. Ross Fiziol Zh Im I M Sechenova; 2007 Jun; 93(6):661-9. PubMed ID: 17850024 [Abstract] [Full Text] [Related]